Relationship between interstitial and blood glucose during hypoglycemia in subjects with type 2 diabetes

Diabetes Technology and Therapeutics

Volumn 13, Issue 11, 2011, Pages 1121-1127

  Choudhary, Pratik ^a   Lonnen, Kathryn ^b   Emery, Celia J ^a   Freeman, Jenny V ^c   McLeod, Ken M ^b   Heller, Simon R ^a  

^a Academic Unit of Diabetes Endocrinology and Metabolism and   (United Kingdom)

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; METFORMIN; NEUTRAL INSULIN; ROSIGLITAZONE; SULFONYLUREA;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE TITRATION; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; INTERSTITIAL FLUID; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; EXTRACELLULAR FLUID; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SULFONYLUREA COMPOUNDS;

EID: 80055057252     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2011.0059     Document Type: Article

References (23)

1. Kaufman FR, Gibson LC, Halvorson M, Carpenter S, Fisher LK, Pitukcheewanont P: A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care 2001;24:2030-2034. (Pubitemid 33716516)
2. Schiaffini R, Ciampalini P, Fierabracci A, Spera S, Borrelli P, Bottazzo GF, Crinò A: The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk. Diabetes Metab Res Rev 2002;18: 324-329.
3. Tanenberg R, Bode B, Lane W, Levetan C, Mestman J, Harmel AP, Tobian J, Gross T, Mastrototaro J: Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. Mayo Clin Proc 2004;79:1521-1526. (Pubitemid 39578876)
4. UK Hypoglycemia Study Group: Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007;50:1140-1147.
5. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476.
6. Aussedat B, Dupire-Angel M, Gifford R, Klein JC, Wilson GS, Reach G: Interstitial glucose concentration and glycemia: implications for continuous subcutaneous glucose monitoring. Am J Physiol Endocrinol Metab 2000;278:E716-E728. (Pubitemid 30215184)
7. Steil GM, Rebrin K, Mastrototaro J, Bernaba B, Saad MF: Determination of plasma glucose during rapid glucose excursions with a subcutaneous glucose sensor. Diabetes Technol Ther 2003;5:27-31. (Pubitemid 36506087)
8. Steil GM, Rebrin K, Hariri F, Jinagonda S, Tadros S, Darwin C, SaadMF: Interstitial fluid glucose dynamics during insulininduced hypoglycaemia. Diabetologia 2005;48:1833-1840. (Pubitemid 41317838)
9. McGowan K, Thomas W, Moran A: Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. Diabetes Care 2002;25:1499-1503. (Pubitemid 41071101)
10. Caplin NJ, O'Leary P, Bulsara M, Davis EA, Jones TW: Subcutaneous glucose sensor values closely parallel blood glucose during insulin-induced hypoglycaemia. Diabet Med 2003;20:238-241. (Pubitemid 36390741)
11. Monsod TP, Flanagan DE, Rife F, Saenz R, Caprio S, Sherwin RS, Tamborlane WV: Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia? Diabetes Care 2002; 25:889-893. (Pubitemid 41094288)
12. Cheyne EH, Cavan DA, Kerr D: Performance of a continuous glucose monitoring system during controlled hypoglycaemia in healthy volunteers. Diabetes Technol Ther 2002; 4:607-613. (Pubitemid 35283323)
13. De MG, Laurenti O, Moretti A: Comparison of glycaemic control in patients with Type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment: results of a pilot study. Acta Diabetol 2009;46:67-73.
14. Lu H, Castells S, Hagerty D, Quintos JB: Study of glucose profiles with continuous glucose monitoring in adolescents with poorly controlled type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2008;21:729-736.
15. McNally PG, Dean JD, Morris AD, Wilkinson PD, Compion G, Heller SR: Using continuous glucose monitoring to measure the frequency of low glucose values when using biphasic insulin aspart 30 compared with biphasic human insulin 30: a double-blind crossover study in individuals with type 2 diabetes. Diabetes Care 2007;30:1044-1048. (Pubitemid 46684622)
16. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P: Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 1994;94:2511-2515. (Pubitemid 24379629)
17. Choudhary P, Lonnen K, Emery CJ, MacDonald IA, MacLeod KM, Amiel SA, Heller SR: Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin-and sulphonylurea-treated Type 2 diabetes. Diabet Med 2009;26:665-672.
18. Liu D, Moberg E, Kollind M, Lins PE, Adamson U, Mac-Donald IA: Arterial, arterialized venous, venous and capillary blood glucose measurements in normal man during hyperinsulinaemic euglycaemia and hypoglycaemia. Diabetologia 1992;35:287-290.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28: 412-419. (Pubitemid 15018832)
20. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310. (Pubitemid 16134762)
21. Oldham PD: Measurement in Medicine: The Interpretation of Numerical Data. London: English Universities Press, 1968.
22. Diabetes Research in Children Network (DirecNet) Study Group: The accuracy of the CGMS in children with type 1 diabetes: results of the Diabetes Research in Children Network (DirecNet) accuracy study. Diabetes Technol Ther 2003;5:781-789.
23. Wallace TM, Levy JC, Matthews DR: Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-1495. (Pubitemid 38680001)